טוען...
Infliximab Therapy for Children with Moderate to Severe Ulcerative Colitis: A Step-Up versus a Top-Down Strategy
PURPOSE: We aimed to investigate clinical outcomes between top-down (TD) and conventional step-up (SU) therapies in pediatric patients with moderate to severe ulcerative colitis (UC). MATERIALS AND METHODS: All patients underwent clinical and endoscopic evaluation at diagnosis and 4 months and 1 yea...
שמור ב:
| הוצא לאור ב: | Yonsei Med J |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Yonsei University College of Medicine
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8236348/ https://ncbi.nlm.nih.gov/pubmed/34164958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2021.62.7.608 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|